| Drug Name |
Reboxetine |
| Drug ID |
BADD_D01919 |
| Description |
Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine. |
| Indications and Usage |
For the treatment of clinical depression. |
| Marketing Status |
approved; experimental |
| ATC Code |
N06AX18 |
| DrugBank ID |
DB00234
|
| KEGG ID |
D08472
|
| MeSH ID |
D000077593
|
| PubChem ID |
127151
|
| TTD Drug ID |
D0N8FQ
|
| NDC Product Code |
Not Available |
| UNII |
947S0YZ36I
|
| Synonyms |
Reboxetine | Reboxetine Mesylate | 2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate | Vestra |
